Objectives This study sought to evaluate the relationship between post-stent strut apposition and follow-up strut coverage using contour plot optical coherence tomographic analysis.
The drug-eluting stent (DES) is a standard modality to treat patients with symptomatic coronary artery disease. However, incomplete neointimal coverage is regarded as an important pathological parameter of late stent thrombosis in patients treated with DES implantation (1, 2) . In particular, it has been demonstrated that following DES implantation, there was a greater prevalence of malapposed and uncovered struts leading to increased risk of late stent thrombosis (3, 4) . Stent strut apposition and the serial change of neointimal formation in cross-sectional images of implanted stents have previously been evaluated by intravascular ultrasound (IVUS) (5, 6) . Recently, optical coherence tomography (OCT) has been used as a powerful high-resolution imaging modality that can provide more detailed information on vascular responses to DES versus IVUS (7) (8) (9) . Although OCT can more accurately detect minimal neointimal coverage over the struts, it is still difficult or even impossible to compare struts between 2 time points (7, 10, 11) . Recently, contour plot OCT reconstruction was successfully used for assessing the spatial distribution pattern of strut coverage and stent malapposition at the strut level (12) . This technique is also able to visualize both the gap between the underlying artery wall and the stent struts after intervention and the neointimal coverage at follow-up in the circumferential and longitudinal directions. The objective of this study was to investigate the relationship between post-stent strut apposition and 6-month follow-up strut coverage using contour plot OCT analysis.
Methods
Study design. A total of 82 stents in 82 patients (37 biolimus A9-eluting stents [Nobori, Terumo Corporation, Tokyo, Japan] and 45 sirolimus-eluting stents [Cypher, Cordis Corp., Miami Lakes, Florida]) were selected from 120 patients enrolled in a randomized trial comparing the strut coverage of the biolimus A9-eluting and sirolimus-eluting stents by an optical coherence tomography analysis (13) . Thirty-eight stents were excluded for the following reasons: follow-up angiogram was not performed (n ¼ 7); the OCT catheter could not be advanced through the lesion due to severe angulation (n ¼ 5); poor image quality in patients (n ¼ 8); reconstruction of contour plots image was not possible in patients due to severe motion artifacts (n ¼ 12); and mismatch of the contour plots between post-intervention and follow-up (n ¼ 6). OCT examination was performed after the procedure and at a 6-month follow-up. Inclusion and exclusion criteria for this study were provided in a previous study (13) . This study was approved by the institutional review board of our institution, and written consent was obtained from all enrolled patients.
OCT imaging and analysis. OCT imaging of the target lesion was performed after the procedure and at the 6-month follow-up using a frequency-domain OCT system (C7-XR OCT imaging system, LightLab Imaging, Inc., St. Jude Medical, St. Paul, Minnesota) developed to generate frames at much higher rates and faster pullback speeds compared with those of time-domain OCT. In this study, OCT cross-sectional images were generated at a rate of 100 frames/s, whereas the fiber was withdrawn at a speed of 20 mm/s within the stationary imaging sheath. A continuous, nonocclusive contrast-saline mixture was flushed through a guiding catheter at a rate of 4 to 5 ml/s for 3 to 4 s. During OCT image acquisition, the OCT catheter was placed as close as possible to a similar location on 6-month follow-up based on the post-intervention image to reduce the difference of the acquired OCT images between 2 time points. All OCT images were analyzed at a core laboratory (Cardiovascular Research Center, Seoul, Korea) by analysts who were blinded to patient and procedural information. Cross-sectional OCT images were analyzed at 0.2-mm intervals. A strut was defined as an embedded strut if the endoluminal strut boundary was below the level of luminal surface (14) . An apposed strut was defined as a strut completely attached to the vessel wall without any gap between itself and the wall. A malapposed strut was defined as a strut that had detached from the vessel wall by !130 mm (biolimus A9-eluting stent) or !160 mm (sirolimus-eluting stent) (15, 16) . Stent and luminal crosssectional areas (CSAs) were measured; neointimal hyperplasia (NIH) CSA was calculated as the stent CSA minus the luminal CSA. NIH thickness was measured as the distance between the endoluminal surface of the neointima and the strut (17) . An uncovered strut was defined as having an NIH thickness of 0 mm (17) . The percentage of uncovered or malapposed struts was calculated as the ratio of uncovered or malapposed struts to total struts in all OCT cross sections. Stent malapposition was further classified into persistent, resolved, or late acquired by comparing the post-procedure and follow-up OCT images (18) . To evaluate the magnitude of malapposition, the maximal extra-stent lumen CSA and the distance between the malapposed strut and the vessel wall (the strut-artery distance) were measured. In addition, tissue prolapse was defined as a mass protruding into the lumen (more than 250 mm at the thickest point).
Volumetric OCT assessment of stent strut apposition using a contour plot. Post-intervention and follow-up contour plot analyses were used to compare vascular responses as previously described (12) . Briefly, the post-intervention strut-artery distance and NIH thickness over the entire stent at follow-up were measured as a function of circumferential arc length and longitudinal stent length from frames with 0.2-mm intervals (Fig. 1) . At the postinterventional period, individual stent struts were divided as apposed, malapposed, embedded (with and without tissue prolapse), or side-branch. At the follow-up, stents were classified as uncovered, malapposed, or side-branch (Fig. 2) . The post-interventional strut-artery distance was measured as a negative value. At follow-up, covered struts had a positive NIH thickness value, whereas the uncovered-malapposed struts had a negative value. Finally, the status of post-stent struts (i.e., embedded, apposed, or malapposed) were monitored and matched as covered, uncovered, or malapposed at the follow-up. See Figure 3 for representative contour plots. To compare the status of struts between the post-intervention and follow-up contour plots, the 2 plots are coregistered based on the location of a side branch as follows. First, the postintervention contour plot is selected as the reference. Second, the pattern of stent structure is compared after the remaining follow-up contour plot is spatially registered to align with the reference by shifting arc length to match the location of a side branch at the 2 plots and for the vessel without side branches. Finally, the status of DES struts is quantitatively analyzed. To show the accuracy of the coregistration of the 2 contour plots, we calculated the averages and standard deviations of the total arc length values, which are used to generate the plots at both post-intervention and follow-up, and the difference of the values is then assessed (Fig. 4 ). Here, SD shows how much the stent structure is distorted at a single time point and the average difference represents the accuracy of coregistration of the contour plots between postintervention and follow-up.
Coronary intervention and quantitative coronary angiography analysis. All patients received at least 75 mg of aspirin and a loading dose of 300 mg of clopidogrel at least 12 h before percutaneous coronary intervention. Unfractionated heparin was administered to maintain the activated clotting time >250 s. All percutaneous coronary interventions were performed according to current standard techniques. Post-procedure, dual antiplatelet therapy of Statistical analysis. Categorical data are presented as numbers (percentages) and compared with chi-square statistics or Fisher's exact test. Continuous data are presented as mean AE SD or median (interquartile range) and compared using the paired t test. If the distributions were skewed, a nonparametric test was used. To avoid problems associated with sample size inflation and correlated data, patients with only 1 target lesion were included for the study. Crosssection or strut-level analysis was not straightforward because struts congregate within each lesion under each individual. For this analysis, multilevel regression model was applied with random effects within the patient level because of the clustering nature of data (13) . Specifically, we used Friedman's test for the comparisons according to the status of post-stent struts and Wilcoxon's rank sum test for the comparisons according to the stent type and tissue prolapse (Online Table 1 ). The significance of poststent struts status was decided by comparing multilevel models with the variable to a null model. Then, we estimated the effect of embedded and malapposed struts compared with apposed struts (Online Table 1 ). Interactions between the variables were not included in the model because none of them was significant. Statistical analysis was performed with the Statistical Analysis System software (SAS, version 9.1.3, SAS Institute, Cary, North Carolina). A value of p < 0.05 denoted statistical significance.
Results
Baseline clinical and angiographic findings of the 82 enrolled patients are summarized in Table 1 . The mean follow-up period was 185 AE 13 days. Post-intervention and follow-up OCT procedures were performed in all patients with no complications or adverse events. OCT data are shown in Table 2 . The percentage of embedded struts after intervention was 1.8% (IQR: 0.6% to 6.2%). Interobserver and intraobserver variability for embedded struts in this study (A) Most of stent struts are well-apposed post-intervention (white arrows), whereas a smaller portion of them were covered (yellow arrows) or uncovered (red arrows) at the 6-month follow-up. (B) Some of stent struts were malapposed post-intervention (white arrows) and are uncovered (yellow arrows) at 6-month follow-up. (C) Some of stent struts are embedded without tissue prolapse post-intervention (white arrows) and are completely covered (yellow arrows) at the 6-month follow-up. (D) Some of stent struts were embedded with tissue prolapse post-intervention (white arrows) and were uncovered (yellow arrows) at the 6-month follow-up.
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Using a computer-generated contour plot, the serial quantitative analysis of embedded, apposed, and malapposed struts after intervention showed a significantly different pattern of stent strut coverage (the percentage of uncovered struts; 0% [IQR: 0% to 11.4%] in embedded, 16.3% [IQR: 8.1% to 33.3%] in apposed, and 26.8% [IQR: 0% to 56.3%] in malapposed struts, p < 0.001 for all pairwise comparisons). Particularly, in lesions without tissue prolapse, embedded struts were all covered (100% covered struts) in comparison to those with tissue prolapse (76.8% covered, p < 0.001) ( Table 3) . Typical examples are shown in Figure 5 . Comparing the same malapposed struts at post-intervention to follow-up showed that 95% of the acute strut malapposition cases were classified as resolved at follow-up, and late acquired malapposition developed in 0.6% of the initially well-apposed struts. There was a lower tendency in the percentage of uncovered struts at 6 months in biolimus-eluting stents (13 The representative contour plot images of both the biolimusand sirolimus-eluting stents are provided in Figure 6 . The mean of average difference of the total arc length values between post-intervention and follow-up is 0.16 AE 0.08 mm (Fig. 4) . It is more than 0.7 mm in 6 excluded cases with mismatch of the contour plots between post-intervention and follow-up.
Discussion
This is the first study to evaluate the impact of post-intervention strut apposition on strut coverage at follow-up using contour map OCT analysis, which enables the serial tracking of specific regions of interest of stent. The present analysis provides an intuitive understanding of the sequential neointimal healing process after stent implantation. This study demonstrates that embedded and apposed struts after 
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The neointimal coverage at follow-up as a function of circumferential arc length and stent length in a 3.0 Â 18-mm biolimus-eluting stent; uncovered struts and struts crossing over the side branches are indicated with blue and orange circles, respectively. Grayscale indicates a stent strut coverage thickness range of -0.1 to 0.6 mm. (C) At a stent length of 13.6 mm from the distal stent margin, a malapposed strut at postintervention turns into an uncovered strut at follow-up without malapposition (red arrows on contour plots and cross sections) in A and A 0 . At a stent length of 6.0 mm from the distal stent margin, an embedded strut becomes a covered strut (green arrows) in B and B 0 . At a stent length of 4.6 mm from the distal stent margin, a malapposed strut post-intervention becomes a covered strut without malapposition at follow-up (blue arrows) in C and C 0 .
intervention had a higher rate of stent strut coverage at 6 months than was observed in malapposed struts. Particularly, embedded struts, compared with apposed struts, improved strut coverage. Based on these results, OCTguided procedural optimization of stent strut apposition can enhance the strut coverage. Because the incomplete re-endothelialization and stent strut coverage were reported to be associated with late stent thrombosis after DES implantation (19) , there have been numerous attempts to evaluate the status of stent struts after intervention and at follow-up by both IVUS and OCT imaging. Using IVUS to evaluate strut status is limited due to the innate low resolution of the technique. A previous study (7) clearly demonstrated the limitations of IVUS resolution by directly comparing the rate of strut coverage assessed by OCT versus IVUS in the same set of stents (25.8% with IVUS vs. 99.9% with OCT). The advent of 3-dimensional OCT reconstructions allows for the visualization of the microstructure of coronary arteries in patients. However, when using current OCT analysis methods, it remains challenging to compare specific regions of struts between baseline and follow-up with serial OCT examinations, and the actual comparison of specific regions at the strut level between 2 time points is impractical in the clinical setting. Overcoming these challenges could help accurately match and compare specific regions of struts between 2 time points and lead to a more accurate risk Values are mean AE SD, n (%), or median (interquartile range).
assessment of stent thrombosis (10) . In this study, we demonstrate that by using a contour plot OCT analysis, the serial assessment of specific regions at the strut level is practical, and the comprehensive monitoring of stent strut status between baseline and follow-up provides useful information about vascular healing status after DES implantation.
The extent of stent strut coverage is influenced by a number of factors, including patient and lesions characteristics, stent type, and procedural factors (7) (8) (9) (10) (11) . The procedural factors can be modified by using OCTguided procedural optimization to improve strut apposition to the vessel wall leading to a decrease in the extent of uncovered stent struts. The clinical significance of apposed versus embedded struts after intervention has not been sufficiently evaluated. One recent report indicated that embedded struts did not correlate with stent strut coverage and neointimal formation (20) . It should be noted that the meticulous serial tracking between post-intervention and follow-up of each individual strut at the strut level was not performed in this study (20) . Our study demonstrates the beneficial effects of strut coverage in embedded struts versus apposed or malapposed struts (the median percentage of uncovered struts was 0% in embedded vs. 16.3% in apposed or 26.8% in malapposed struts, p < 0.001 for all pairwise comparisons). In addition, we found that the percentage of uncovered struts in the presence or absence of tissue prolapse within the stent was significantly different in the subgroup of embedded struts. In cases without prolapse, embedded struts were all covered (100%) versus those with tissue prolapse (76.8%, p < 0.01). This difference might be explained by the nature of prolapsed tissue within the stent. Although we cannot clearly define the characteristics of the prolapsed tissue (because pre-intervention OCT was not performed), we speculate that the prolapsed tissue might be thrombus based on post-intervention OCT images. Thrombus compression/displacement by the stent strut occurred during the coronary intervention procedure, and both the abluminal and luminal thrombi were generally resolved by the time of the follow-up in the embedded struts (21) . Based on these findings, we assert that optimizing stent apposition by using OCT guidance leads to improvements in the stent strut coverage early after DES implantation. When early strut coverage is accurately assessed in selected patients with coronary artery disease, this information can be used to determine the appropriate treatment strategy, leading to a shorter duration of dual antiplatelet therapy after DES implantation. Recent studies reported that the degree of OCT-assessed stent strut coverage may be associated with future cardiac events (3, 22) . However, there remains a concern that stent optimization for embedding the stent struts into the vessel wall may increase myocardial or arterial injury. The need for further studies is, therefore, warranted. Blue, red, and green circles indicate embedded, malapposed, and apposed struts, respectively. Nearly all embedded struts (blue circle) showed complete strut coverage at 6 months (A). Apposed struts (green circle) were uncovered in some proportion (A) and covered in the other proportion at 6 months (B). However, many malapposed struts (red circle) were not covered without any gap between the strut and the vessel walls at 6 months (A and B).
Previous IVUS studies reported favorable long-term clinical outcomes of acute stent malapposition after DES implantation (23, 24) . However, the exact mechanisms to explain these favorable outcomes remain unexplained. In the present study, using contour plot analysis we show that 95% of struts classified as malapposed after the procedure were classified as resolved at follow-up. These findings may partly explain the favorable long-term clinical outcomes of acute stent malapposition after DES implantation. However, acute malapposed struts are still associated with a greater incidence of uncovered struts, despite our data. A previous OCT study examining sirolimus-eluting stents suggested that strut coverage at 6 months may be delayed in post-intervention malapposed struts compared with strut coverage in post-intervention apposed struts (the rate of uncovered strut: 65% in malapposed vs. 9% in apposed strut post-intervention) (25) . Another OCT study similarly reported a higher incidence of uncovered struts in malapposed struts after DES implantation (72.6%) (10) . In this study, the median percentage of uncovered struts was also greater in malapposed struts (26.8%) than in apposed struts (16.3%). The discrepancy between favorable long-term clinical outcomes and the increased rate of uncovered struts in acute stent malapposition requires further investigation. The subsequent clinical outcomes and status of uncovered struts in acute stent malapposition may be affected by the initial clinical presentation, underlying plaque characteristics, types of DES used, and the duration of dual antiplatelet therapy. A proper study design and implementation will help alleviate these complications. Study limitations. It should be noted that the OCT cross sections contain artifacts such as guidewire shadowing, nonuniform rotational distortion of mechanical catheter systems, displacement of catheter position inducing sunflower artifacts, and motion artifacts caused by cardiac dynamics. Therefore, significant motion effects may limit this assessment of coregistration by calculating arc length values. The association between plaque characteristics at pre-intervention and follow-up was not evaluated in this study. The current OCT system cannot detect endothelial cells and is limited for the evaluation of true endothelialization. Furthermore, the differentiation of normal neointimal tissue from fibrin or thrombus over the stent struts is not possible. This study could not adequately evaluate the impact of contour plot analysis on clinical outcomes because of the relatively small population and proportion of embedded struts. Two types of DESs were used. From a practical standpoint, an automated system with instantaneous image interpretation should be required for clinical feasibility. This study was performed at the strut level. However, there was a possibility that the healing pattern might be different at the patient or stent level. Finally, although statistical analysis in this study did not completely solve the problems of clustering of the OCT data, the impact on the final results was minimal.
